Vivimed Labs shines on exporting first shipment of Famotidine tablets to Canada

Vivimed Labs is currently trading at Rs. 29.70, up by 1.40 points or 4.95% from its previous closing of Rs. 28.30 on the BSE.

The scrip opened at Rs. 27.60 and has touched a high and low of Rs. 29.70 and Rs. 26.90 respectively. So far 285596 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 2 has touched a 52 week high of Rs. 41.50 on 28-Apr-2021 and a 52 week low of Rs. 9.70 on 27-May-2020.

Last one week high and low of the scrip stood at Rs. 33.80 and Rs. 27.00 respectively. The current market cap of the company is Rs. 246.25 crore.

The promoters holding in the company stood at 28.57%, while Institutions and Non-Institutions held 3.22% and 68.21% respectively.

Vivimed Labs has exported the first shipment of Famotidine tablets that work by decreasing the amount of acid in the stomach, to Canada. The export to Canada is for Famotidine tablets in the strengths of 40mg and 20mg.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.